Article Cited by others

INVITED RESEARCH HIGHLIGHT

Next generation patient-derived prostate cancer xenograft models

Lin Dong, Xue Hui, Wang Yuwei, Wu Rebecca, Watahiki Akira, Dong Xin, Cheng Hongwei, Wyatt Alexander W, Collins Colin C, Gout Peter W, Wang Yuzhuo

Year : 2014| Volume: 16| Issue : 3 | Page no: 407-412

   This article has been cited by
 
1 The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Abhijit Parolia,Erik Venalainen,Hui Xue,Rebecca Mather,Dong Lin,Rebecca Wu,Perla Pucci,Jason Rogalski,Joseph R. Evans,Felix Feng,Colin C. Collins,Yuzhuo Wang,Francesco Crea
Molecular Oncology. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 Translational models of prostate cancer bone metastasis
Richard B. Berish,Aymon N. Ali,Patrick G. Telmer,John A. Ronald,Hon S. Leong
Nature Reviews Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Prostate cancer xenografts and hormone induced prostate carcinogenesis
Dalton T. McLean,Douglas W. Strand,William A. Ricke
Differentiation. 2017; 97: 23
[Pubmed]  [Google Scholar] [DOI]
4 Patient-derived xenografts as in vivo models for research in urological malignancies
Takahiro Inoue,Naoki Terada,Takashi Kobayashi,Osamu Ogawa
Nature Reviews Urology. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX
Domenica Rea,Vitale del Vecchio,Giuseppe Palma,Antonio Barbieri,Michela Falco,Antonio Luciano,Davide De Biase,Sisto Perdonà,Gaetano Facchini,Claudio Arra
BioMed Research International. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
6 Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine
Zhijun Wang,Xuefeng Liu,Rebecca Ho,Christopher Lam,Moses Chow
Molecules. 2016; 21(7): 889
[Pubmed]  [Google Scholar] [DOI]
7 A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses
R R Naik,A K Singh,A M Mali,M F Khirade,S A Bapat
Oncogene. 2016; 35(6): 727
[Pubmed]  [Google Scholar] [DOI]
8 Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy
Manish Kohli,Liguo Wang,Fang Xie,Hugues Sicotte,Ping Yin,Scott M. Dehm,Steven N. Hart,Peter T. Vedell,Poulami Barman,Rui Qin,Douglas W. Mahoney,Rachel E. Carlson,Jeanette E. Eckel-Passow,Thomas D. Atwell,Patrick W. Eiken,Brendan P. McMenomy,Eric D. Wieben,Gautam Jha,Rafael E. Jimenez,Richard Weinshilboum,Liewei Wang,Natasha Kyprianou
PLOS ONE. 2015; 10(12): e0145176
[Pubmed]  [Google Scholar] [DOI]
9 Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity
Tianwei Zhang,Lin Zhang,Shuqiong Fan,Meizhuo Zhang,Haihua Fu,Yuanjie Liu,Xiaolu Yin,Hao Chen,Liang Xie,Jingchuan Zhang,Paul R. Gavine,Yi Gu,Xingzhi Ni,Xinying Su,Eric Asselin
PLOS ONE. 2015; 10(7): e0134493
[Pubmed]  [Google Scholar] [DOI]
10 Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice
Christian Wetterauer,Tatjana Vlajnic,Julia Schüler,Joel R. Gsponer,George N. Thalmann,Marco Cecchini,Julia Schneider,Tobias Zellweger,Heike Püschel,Alexander Bachmann,Christian Ruiz,Stephan Dirnhofer,Lukas Bubendorf,Cyrill A. Rentsch
The Prostate. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
11 Drug discovery in prostate cancer mouse models
Kenneth C Valkenburg,Kenneth J Pienta
Expert Opinion on Drug Discovery. 2015; : 1
[Pubmed]  [Google Scholar] [DOI]
12 Subrenal capsule grafting technology in human cancer modeling and translational cancer research
Yuzhuo Wang,Joy X. Wang,Hui Xue,Dong Lin,Xin Dong,Peter W. Gout,Xin Gao,Jun Pang
Differentiation. 2015;
[Pubmed]  [Google Scholar] [DOI]
13 Establishing prostate cancer patient derived xenografts: Lessons learned from older studies
Pamela J. Russell,Peter Russell,Christina Rudduck,Brian W-C Tse,Elizabeth D. Williams,Derek Raghavan
The Prostate. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]

 

Read this article